The company, founded by Aaron Esteron in 1992, is a world leader in Platelet-Rich Plasma (PRP) therapy and offers a unique patented FDA and CE technology that delivers progressive non-surgical healing treatment in multiple applications such as aesthetics, orthopedics, wound management, dental, cardiology, ophthalmology, veterinary and more. Their flagship products, Tropocells® and Cellenis® PRP technologies, are marketed in over 50 countries worldwide. Estar Medical is committed to innovation and quality, and is creating the next generation of its proprietary Tropocells® platform technology.